Department of Molecular Biology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
Atherosclerosis Study Group, Instituto Nacional de Cardiología Ignacio Chavez, Mexico City, Mexico.
PLoS One. 2019 Sep 6;14(9):e0222017. doi: 10.1371/journal.pone.0222017. eCollection 2019.
It has recently been reported that the sterol regulatory element-binding transcription factors (SREBF-1c, and -2) contribute to the variation in the plasma lipids levels, which have an important role in the atherosclerotic plaque development. The aim of the present study was to evaluate whether the SREBF1c and SREBF2 gene single nucleotide polymorphisms (SNPs) are associated with plasma lipids levels and ACS susceptibility in a case-control association study.
A case-control study was carried out in 625 patients with ACS (82% men and 18% women, with a mean age of 57.97 ± 10.5 years) and 700 healthy controls (66% men and 34% women, with a mean age of 54.37 ± 7.65 years). The sample size was calculated for a statistical power of 80%. We genotyped three SREBF1c (rs2297508, rs11656665 and rs11868035) and three SREBF2 (rs2267439, rs2267443, and rs2228314) gene polymorphisms by 5' exonuclease TaqMan assays. The associations were evaluated by logistic regression under the co-dominant, dominant, recessive, over-dominant and additive inheritance models. The contribution of the genotypes on the plasma lipids levels was evaluated by Student's t-test.
Under different models, the SREBF1c rs2297508 (OR = 1.50, pCRes = 0.03), SREBF1c rs11656665 (OR = 1.35, pCDom = 0.02 and OR = 1.26, pCAdd = 0.02) and SREBF2 rs2228314 (OR = 1.78, pCRes = 0.03, OR = 1.27, pCAdd = 0.04) SNPs were associated with higher risk of ACS. On the other hand, the SREBF1c rs11868035 SNP was associated with lower risk of ACS (OR = 0.49, pCCo-dom = 0.001, OR = 0.66, pCDom = 0.003, OR = 0.57, PRes = 0.003 and OR = 0.71, pCAdd = 0.001). There was a statistically significant association of both SREBF1c rs11656665 and rs11868035 polymorphisms with plasma triglyceride levels.
In summary, our data suggest the association of the SREBF1c and SREBF2 SNPs with risk of developing ACS and with triglyceride levels in a Mexican population.
最近有报道称,固醇调节元件结合转录因子(SREBF-1c 和 -2)有助于血浆脂质水平的变化,而这些变化在动脉粥样硬化斑块的发展中起着重要作用。本研究旨在评估 SREBF1c 和 SREBF2 基因单核苷酸多态性(SNPs)是否与病例对照关联研究中的血浆脂质水平和 ACS 易感性相关。
对 625 名 ACS 患者(82%为男性,18%为女性,平均年龄为 57.97±10.5 岁)和 700 名健康对照者(66%为男性,34%为女性,平均年龄为 54.37±7.65 岁)进行了病例对照研究。计算了样本量,以达到 80%的统计功效。我们通过 5'外切核酸酶 TaqMan 测定法对三个 SREBF1c(rs2297508、rs11656665 和 rs11868035)和三个 SREBF2(rs2267439、rs2267443 和 rs2228314)基因多态性进行了基因分型。采用协方差、显性、隐性、超显性和加性遗传模型下的逻辑回归评估相关性。采用学生 t 检验评估基因型对血浆脂质水平的影响。
在不同模型下,SREBF1c rs2297508(OR=1.50,pCRes=0.03)、SREBF1c rs11656665(OR=1.35,pCDom=0.02 和 OR=1.26,pCAdd=0.02)和 SREBF2 rs2228314(OR=1.78,pCRes=0.03,OR=1.27,pCAdd=0.04)SNP 与 ACS 风险增加相关。另一方面,SREBF1c rs11868035 SNP 与 ACS 风险降低相关(OR=0.49,pCCo-dom=0.001,OR=0.66,pCDom=0.003,OR=0.57,pRes=0.003 和 OR=0.71,pCAdd=0.001)。SREBF1c rs11656665 和 rs11868035 多态性与血浆甘油三酯水平之间存在统计学显著关联。
综上所述,我们的数据表明,SREBF1c 和 SREBF2 SNPs 与墨西哥人群 ACS 发病风险和甘油三酯水平相关。